UNC926 hydrochloride
CAS No. 1782573-49-2
UNC926 hydrochloride( —— )
Catalog No. M23797 CAS No. 1782573-49-2
UNC926 hydrochloride is a methyl-lysine (Kme) reader domain inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 178 | In Stock |
|
| 5MG | 172 | In Stock |
|
| 10MG | 258 | In Stock |
|
| 25MG | 426 | In Stock |
|
| 50MG | 586 | In Stock |
|
| 100MG | 792 | In Stock |
|
| 200MG | 1051 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUNC926 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionUNC926 hydrochloride is a methyl-lysine (Kme) reader domain inhibitor.
-
DescriptionUNC926 hydrochloride is a methyl-lysine (Kme) reader domain inhibitor.
-
In VitroUNC926 also exhibits a low micromolar affinity for the close homolog, L3MBTL3 ( IC50 of 3.2 μM), with a decrease in affinity for the other MBT domains and no binding to CBX7.UNC926 (1-25 μM) inhibits binding of the 3xMBT domain to H4K20me1.UNC926 inhibits the association of L3MBTL13xMBT with the appropriate histonepeptides in a dose-dependent manner. UNC926 does not have an effect on the binding of 53BP1 to H4K20me1, demonstrating specificity of UNC926 for L3MBTL1 over 53BP1.
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorL3MBTL1|L3MBTL3|L3MBTL4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1782573-49-2
-
Formula Weight373.72
-
Molecular FormulaC16H22BrClN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:150 mg/mL?(444.77 mM)
-
SMILESO=C(C1=CC=CC(Br)=C1)N2CCC(N3CCCC3)CC2.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Herold JM, et al. Structure-activity relationships of methyl-lysine reader antagonists. MedChemComm. 2012;3(45):45-51.
molnova catalog
related products
-
Menin-MLL inhibitor ...
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
-
XD14
XD14 is an inhibitor of BET bromodomain (Kd of 160 nM, 170 nM, 380 nM, 490 nM, 830 nM and 850 nM for BRD4(1), BRD2(1), BRD3(1), BRD3(2), BRD2(2) and BRD4(2), respectively).
-
3-methyl-1,2-dihydro...
3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
Cart
sales@molnova.com